Skip to content

Efficacy of TachoSil on air leakage in chest surgery - ND

Efficacy of TachoSil on air leakage in chest surgery - ND

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-006001-16-IT
Enrollment
Unknown
Registered
2009-03-31
Start date
2008-12-10
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient undergone lobectomy or segmentectomy (anatomical segmentectomy) for lung carcinoma and that during intraoperative phase after first suture with stapler show air leakage with grade 1-2 according to the Macchiarini scale. MedDRA version: 9.1 Level: SOC Classification code 10038738

Interventions

Trade Name: TACHOSIL Pharmaceutical Form: Sealant INN or Proposed INN: FIBRINOGENO UMANO Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 5,5- INN or Proposed INN: T

Sponsors

AZIENDA UNITA` SANITARIA LOCALE LECCE
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Giving Written Informed Consent - Male and female patients - Age >= 18 years - Lobectomy, bilobectomy superior or inferior right, anatomical segmentectomy in patients with malignant carcinoma. If lobectomy was performed, it is mandatory to use stapler for scissures (not electrocautery) - If anatomical segmentectomy was performed, it is mandatory the use of stapler - Macchiarini score 1 or 2 after lobectomy Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: - Previous radio-chemotherapy - Videoassisted surgery - Previous chest surgery - Important pleural adhesions - Emergency surgery

Design outcomes

Primary

MeasureTime frame
Main Objective: This is an open, randomized, prospective study in comparison with standard surgery procedures. The study will be conducted in 17 Thoracic Surgery Units with the aim to evaluate the efficacy of TachoSil application on parenchimal air leakage and to determine its effects on the reduction of incidence/severity intraoperative air leakage, duration of thoracic drainage, duration of post-operative air leakage and hospitalization period.;Secondary Objective: not avalaible;Primary end point(s): Intaoperative air leakage reduction of 1 or 2 degree (from 1 to 0 or from 2 to 1 to 0) estimate with the second water submersion test (Macchiarini test) post-treatment.

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026